GregoryFKeenanMD

Pediatric Rheumatology • Phoenixville, PA

Physician

Join to view full profile

Dr. Keenan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Keenan's full profile

Already have an account?

Office
280 Country Ln
Phoenixville, PA 19460
Phone+1 610-651-6220

Education & Training

University of Pennsylvania Health SystemFellowship, Rheumatology, 1990 - 1993
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pediatrics, 1986 - 1990
Albany Medical CollegeClass of 1986

Certifications & Licensure

CA State Medical License 1987 - Present
PA State Medical License 1990 - 2026
MA State Medical License 1991 - 2016
American Board of Internal Medicine Rheumatology
American Board of Pediatrics Pediatric Rheumatology

Publications & Presentations

PubMed

185 citations
Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease
Jane C. Burns, Brookie M. Best, Asuncion Mejias, Lynn Mahony, David E Fixler
The Journal of Pediatrics. 2008-12-01
122 citations
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controll...
C Antoni, Arthur Kavanaugh, Désirée van der Heijde, A. Beutler, Gregory F. Keenan
The Journal of Rheumatology. 2008-05-01
6 citations
A prospective open-label trial of Remicade in patients with severe exacerbation of Crohn's disease requiring hospitalization: a comparison with outcomes previously obs...
Jyoti K. Bhatia, Burton I. Korelitz, Georgia Panagopoulos, Efrat Z Lobel, Felice Mirsky
Journal of Clinical Gastroenterology. 2007-08-01

Press Mentions

Two Months After Inking a SPAC Deal, Renovacor Taps New CMO; CureVac Reels in a New Development Chief from Merck KGaAJune 4th, 2021
ValenzaBio Appoints Biotech Veteran Gregory Keenan, M.D., as Chief Medical OfficerJune 1st, 2021
Ten Finalists Selected for $75M Bold New Research ApproachMay 18th, 2016